In legal news affecting the biotechnology sector, a Texas federal judge has recently rejected an attempt by Natera Inc., a prominent genetic testing company, to claim it did not infringe upon a patent held by a smaller competitor. Natera’s argument was found to be flawed with respect to particular elements of the patent claims.
The patent in question is owned by a small biotech firm, adding to the complexity of the case. As this matter unfolds, the global legal and corporate community will closely watch for its possible ramifications on patent disputes involving large corporations and smaller entities.
For legal professionals interested in following this story in more depth, further details can be found on Law360.